XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,598,981 | -13.3% | 67,506 | -19.4% | 0.10% | -10.5% |
| Q1 2023 | $2,996,124 | -9.2% | 83,714 | 0.0% | 0.11% | -8.8% |
| Q4 2022 | $3,300,843 | +48.1% | 83,714 | +35.6% | 0.12% | +37.4% |
| Q3 2022 | $2,229,000 | +146.6% | 61,733 | +107.8% | 0.09% | +152.8% |
| Q2 2022 | $904,000 | -65.0% | 29,710 | -82.4% | 0.04% | -56.6% |
| Q3 2021 | $2,583,000 | -17.9% | 169,030 | 0.0% | 0.08% | -18.6% |
| Q2 2021 | $3,147,000 | +6.0% | 169,030 | +1.9% | 0.10% | 0.0% |
| Q1 2021 | $2,970,000 | +133.7% | 165,898 | +71.1% | 0.10% | +112.5% |
| Q4 2019 | $1,271,000 | -15.7% | 96,961 | -40.8% | 0.05% | -15.8% |
| Q2 2018 | $1,507,000 | +9.8% | 163,819 | -41.5% | 0.06% | +7.5% |
| Q1 2018 | $1,372,000 | +38.7% | 280,000 | -20.0% | 0.05% | +39.5% |
| Q4 2017 | $989,000 | -4.3% | 350,000 | 0.0% | 0.04% | +2.7% |
| Q3 2017 | $1,033,000 | -6.3% | 350,000 | 0.0% | 0.04% | -9.8% |
| Q2 2017 | $1,103,000 | -21.2% | 350,000 | 0.0% | 0.04% | -24.1% |
| Q1 2017 | $1,400,000 | -74.0% | 350,000 | -50.0% | 0.05% | -76.5% |
| Q4 2016 | $5,390,000 | -4.9% | 700,000 | 0.0% | 0.23% | +5.5% |
| Q3 2016 | $5,670,000 | – | 700,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
| COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
| TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
| Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
| Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
| GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
| DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
| Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
| Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
| Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |